News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,882 Results
Type
Article (13649)
Company Profile (100)
Press Release (249133)
Section
Business (87977)
Career Advice (464)
Deals (15336)
Drug Delivery (64)
Drug Development (36555)
Employer Resources (49)
FDA (6271)
Job Trends (6190)
News (150096)
Policy (14017)
Tag
Academia (435)
Alliances (23175)
Alzheimer's disease (371)
Approvals (6280)
Artificial intelligence (75)
Bankruptcy (144)
Best Places to Work (4358)
Breast cancer (64)
Cancer (452)
Cardiovascular disease (47)
Career advice (406)
Cell therapy (62)
Clinical research (30636)
Collaboration (239)
Compensation (97)
COVID-19 (752)
C-suite (77)
Data (451)
Diabetes (64)
Diagnostics (1250)
Drug discovery (45)
Drug pricing (59)
Earnings (31637)
Events (37016)
Executive appointments (271)
FDA (6539)
Funding (156)
Gene therapy (72)
GLP-1 (314)
Government (1273)
Healthcare (3542)
Infectious disease (774)
Inflammatory bowel disease (50)
Interviews (58)
IPO (5851)
Job creations (2050)
Job search strategy (372)
Layoffs (170)
Legal (3418)
Lung cancer (64)
Manufacturing (115)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9589)
Metabolic disorders (199)
Neuroscience (498)
NextGen: Class of 2025 (1581)
Non-profit (591)
Northern California (554)
Obesity (119)
Opinion (113)
Patents (70)
People (28655)
Pharmaceutical (63)
Phase I (7980)
Phase II (12953)
Phase III (11632)
Pipeline (232)
Policy (47)
Postmarket research (1401)
Preclinical (3181)
Radiopharmaceuticals (116)
Rare diseases (119)
Real estate (2631)
Regulatory (9935)
Research institute (563)
Resumes & cover letters (55)
Southern California (541)
Startups (1625)
United States (5382)
Vaccines (121)
Weight loss (86)
Date
Today (54)
Last 7 days (182)
Last 30 days (765)
Last 365 days (12370)
2025 (734)
2024 (12500)
2023 (14246)
2022 (19556)
2021 (20070)
2020 (19034)
2019 (14888)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (46)
Asia (19939)
Australia (2577)
California (1300)
Canada (724)
China (170)
Colorado (52)
Connecticut (52)
Europe (39026)
Florida (217)
Illinois (147)
Indiana (104)
Japan (59)
Kansas (53)
Maryland (189)
Massachusetts (1113)
Minnesota (70)
New Jersey (536)
New York (360)
North Carolina (319)
Northern California (554)
Pennsylvania (337)
South America (500)
Southern California (541)
Texas (169)
Virginia (50)
Washington State (85)
262,882 Results for "phio pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee (SMC) Recommendation to Continue to Third Dose Cohort in its Clinical Study of PH-762
Phio’s Lead Compound PH-762 demonstrates encouraging safety profile in 2nd cohort with recommendation to escalate to next dose concentration
December 19, 2024
·
4 min read
Press Releases
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Presenting new clinical data from Phio’s on-going Phase 1b trial
November 7, 2024
·
5 min read
Press Releases
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
New clinical data from Phio’s on-going Phase 1b trial to be presented
October 24, 2024
·
3 min read
Press Releases
Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio’s Patented INTASYL Compound
Phio’s INTASYL compound targets aging skin disorders
August 6, 2024
·
3 min read
Press Releases
Phio Pharmaceuticals Announces Publication in Clinical, Cosmetic and Investigational Dermatology
INTASYL Compound RXI-231: a promising approach to treatment of hyperpigmentation
January 2, 2025
·
5 min read
Press Releases
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Registration Link for Presentation and live Q&A to take place, Wednesday January 29, 2025 at 2:00 pm EST
January 22, 2025
·
4 min read
Press Releases
Phio Pharmaceuticals Announces Publication in Frontiers in Immunology
Journal is the official publication of the International Union of Immunological Societies
December 12, 2024
·
4 min read
Press Releases
Phio Pharmaceuticals is a Finalist for the Technology Disruptor of the Year Award
December 10, 2024
·
5 min read
Press Releases
Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical Study of PH-762
Pathologic Complete Response reported for 2 patients with cutaneous Squamous Cell Carcinoma
January 13, 2025
·
5 min read
Press Releases
Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 21, 2025
·
7 min read
1 of 26,289
Next
